Blair William & CO Dexcom Inc Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Dexcom Inc stock. As of the latest transaction made, Blair William & CO holds 4,532,687 shares of DXCM stock, worth $510 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares

4,532,687

Previous 4,468,004 1.45%

Holding current value

$510 Million

Previous $554 Million 13.39%

% of portfolio

2.0%

Previous 1.91%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$114.22 - $140.1 $7.39 Million - $9.06 Million	64,683 Added 1.45%	4,532,687 $629 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $2.96 Million - $4.86 Million	-39,149 Reduced 0.87%	4,468,004 $554 Million
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $6.34 Million - $10.2 Million	73,654 Added 1.66%	4,507,153 $421 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $8.67 Million - $10.1 Million	77,048 Added 1.77%	4,433,499 $570 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $6.76 Million - $7.99 Million	-64,976 Reduced 1.47%	4,356,451 $506 Million

Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $17 Million - $24.6 Million	-200,321 Reduced 4.33%	4,421,427 $501 Million
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $9.15 Million - $11.3 Million	119,780 Added 2.66%	4,621,748 $372 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $227 Million - $444 Million	3,341,773 Added 288.04%	4,501,968 $336 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $1.83 Million - $2.53 Million	-19,462 Reduced 1.65%	1,160,195 $594 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3.04 Million - $3.81 Million	-23,420 Reduced 1.95%	1,179,657 $633 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $395,360 - $530,481	-3,705 Reduced 0.31%	1,203,077 $658 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1.63 Million - $2.17 Million	20,119 Added 1.7%	1,206,782 $515 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $8.89 Million - $11 Million	104,872 Added 9.69%	1,186,663 $426 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $2.74 Million - $3.67 Million	35,144 Added 3.36%	1,081,791 $400 Million
Q3 2020 Nov 06, 2020	SELL	$95.51 - $112.95 $2.57 Million - $3.03 Million	-26,867 Reduced 2.5%	1,046,647 $431 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $3.88 Million - $6.51 Million	-61,826 Reduced 5.45%	1,073,514 $435 Million
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $3.33 Million - $5.28 Million	-69,749 Reduced 5.79%	1,135,340 $306 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $2.06 Million - $3.23 Million	56,352 Added 4.91%	1,205,089 $264 Million
Q3 2019 Nov 12, 2019	BUY	$35.53 - $43.8 $384,470 - $473,959	10,821 Added 0.95%	1,148,737 $171 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $3.55 Million - $4.96 Million	127,561 Added 12.63%	1,137,916 $171 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $1.26 Million - $1.71 Million	44,803 Added 4.64%	1,010,355 $120 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $495,266 - $685,739	-18,350 Reduced 1.87%	965,552 $116 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $460,018 - $723,420	-19,701 Reduced 1.96%	983,902 $141 Million
Q2 2018 Aug 13, 2018	BUY	$17.54 - $25.22 $781,178 - $1.12 Million	44,537 Added 4.64%	1,003,603 $95.3 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $900,826 - $1.28 Million	-68,976 Reduced 6.71%	959,066 $71.1 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $1 Million - $1.39 Million	-90,264 Reduced 8.07%	1,028,042 $59 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $12.7 Million - $21.2 Million	1,118,306	1,118,306 $54.7 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account